ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Leal Therapeutics raised $30 million in the second close of its Series A funding round. The financing brings additional capital to the company, though the total round size and lead investors were not disclosed.
Tap to vote and see what everyone thinks.
Summary by ByteBrief